IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q2 2020 Holdings

Filed 2020-08-06 | 6 holdings | $93.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$34.0K1,615,32136.3%
Surface Oncology IncCOM86877M209$30.5K4,645,45332.6%
Spero Therapeutics Inc(SPRO)COM84833T103$18.6K1,376,96819.9%
Synlogic IncCOM87166L100$5.4K2,651,9635.8%
Snap Inc(SNAP)CL A83304A106$3.5K150,1603.8%
Unum Therapeutics IncCOM903214104$1.5K3,361,5351.7%